Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Standards for ‘Safe’ Limits of PFCs in Drinking Water Appear too High for Children

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
A new environmental toxicity study has found that exposure limits for perfluorinated compounds (PFCs) found in drinking water appear to be 100 to 1,000 times too high.

PFCs are chemicals widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging.

Philippe Grandjean, adjunct professor of environmental health at HSPH, and Esben Budtz-Jørgensen of the University of Copenhagen, concluded that current exposure limits do not adequately protect children and other vulnerable groups against adverse effects on the human immune system. These same researchers showed in 2012 that routine childhood vaccines are less effective in children exposed to PFCs.

The new study, “Immunotoxicity of perfluorinated alkylates: Calculation of benchmark doses based on serum concentrations in children,” was published online April 18, 2013, in the BioMed Central open access journal Environmental Health.

The researchers compared blood concentration levels of PFCs for 431 five-year-olds in a birth cohort to serum antibody concentrations against tetanus and diphtheria toxoids in the same children at age 7. A doubling in PFC exposure was associated with a 50% decrease in the antibody concentration. As a threshold for this effect could not be identified, the researchers calculated a so-called benchmark dose to identify approximate exposure levels that would protect against the effect. The same method is used by EPA and other agencies.

“Most of the research on PFCs is fairly recent. So it’s no surprise that the EPA limits are already outdated. But if they are more 100 times too high, we need to discuss what went wrong and why the limits were so far off,” Grandjean said.

According to the authors, the discrepancy between the current safe levels and the tolerable exposure levels identified in the new study has occurred because PFCs have not been subjected to systematic toxicity testing, as they were ‘grandfathered’ in when the Toxic Substances Control Act (TSCA) was enacted in the U.S. in 1976. Although production of one of the compounds studied, PFOA (or C8), is currently being phased out in the U.S. and production of another (PFOS) has stopped, exposures continue due to the persistence of these compounds in the environment and in consumer products, and their continued production in other countries.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
Friday, September 23, 2016
Diverse Fungi Secrete Similar Suite of Decomposition Enzymes
A recent study reveals different fungal species secrete a rich set of enzymes that share similar functions, despite species-specific differences in the amino acid sequences of these enzymes.
Tuesday, August 30, 2016
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Thursday, August 25, 2016
Toxic Chemicals Found in Drinking Water of 33 States
High levels of fluorinated compounds have been linked to cancer, hormone disruption.
Thursday, August 11, 2016
New Approach To Severe Bacterial Infections And Sepsis
Protein fragment could provide a defense when antibiotics fail.
Friday, July 08, 2016
Harvard Licenses Genotyping Platform
Novel approach aids development of drug resistance testing products for HIV.
Tuesday, May 24, 2016
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Monday, May 23, 2016
New Weapon Against Breast Cancer
Molecular marker in healthy tissue can predict a woman’s risk of getting the disease, research says.
Thursday, April 07, 2016
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Tuesday, March 22, 2016
Scaling Up Tissue Engineering
Wyss Institute has invented Bioprinting technique that creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine.
Tuesday, March 15, 2016
Into Thin Air
Lower oxygen intake could be used to prevent mitochondrial diseases from forming.
Tuesday, March 01, 2016
High Poverty’s Effect on Childhood Leukemia
Patients more likely to suffer early relapses, which can be harder to treat.
Thursday, February 25, 2016
A Cancer’s Surprise Origins, Caught in Action
First demonstration of a melanoma arising from a single cell.
Monday, February 01, 2016
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Wednesday, January 20, 2016
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Friday, January 08, 2016
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!